Pfizer makes a $4.9 billion bet on obesity drugs with Metsera buyout deal
Metsera’s shareholders could see significant bonuses if certain milestones are reached. www.marketwatch.com #Pfizer #billion #bet #obesity #drugs #Metsera #buyout #deal
Tag: obesity
Eli Lilly obesity pill beats Novo Nordisk drug in diabetes trial
A sign with the company logo sits outside of the headquarters of Eli Lilly in Indianapolis, Indiana, on March 17, 2024.…
Obesity pills from Eli Lilly, Novo Nordisk near US launch
Eli Lilly and Novo Nordisk are preparing to take their rivalry to the next frontier of weight-loss medications: pills. Both…
Obesity now main form of malnutrition afflicting youth: UNICEF | Health News
Published On 10 Sep 202510 Sep 2025 Obesity has outpaced undernourishment to become the leading form of malnutrition worldwide for…
Eli Lilly’s Daniel Skovronsky talks obesity pill data
The Eli Lilly headquarters in Indianapolis, Indiana, on Aug. 15, 2024. AJ Mast | Bloomberg | Getty Images A version…
Eli Lilly’s Obesity Pill Moves Closer to Approval
Eli Lilly & Co.’s experimental obesity pill helped patients lose 9.6% of their body weight in a trial that moves…
Eli Lilly’s obesity pill will rival Novo Nordisk’s oral Wegovy drug
A sign with the company logo sits outside of the headquarters of Eli Lilly in Indianapolis, Indiana, on March 17, 2024.…
Chinese Drugmaker Aiming to Sell Obesity Meds Soars in HK Debut
Guangzhou Innogen Pharmaceutical Group Co., a Chinese biotech firm looking to tap the vast domestic market for obesity drugs, surged…
Eli Lilly obesity pill orforglipron led to 12% weight loss
Eli Lilly on Thursday said the highest dose of its daily obesity pill helped patients lose almost 12% of their…
Novo Soars as Lilly’s Obesity Pill Disappointment Offers Relief
Novo Nordisk A/S shares soared as disappointing data from rival Eli Lilly & Co.’s closely watched obesity pill bolstered investor…